Management strategies for intracranial progression in ALK-positive non-small cell lung cancer: a real-world cohort study
ConclusionThe intracranial progression-free survival showed no difference between the two strategies suggesting that both local radiotherapy and systemic therapy may be valid options. Individualized strategy, molecular analysis, and multidisciplinary conferences may all play a pivotal role in decision-making.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Conferences | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Statistics | Study